Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator

Valor-Mendez L, Dorn C, Manger B, Schett G, Kleyer A (2022)

Publication Type: Journal article, Letter

Publication year: 2022

Journal

Rheumatology Advances in Practice Oxford University Press

Book Volume: 6

Journal Issue: 3

DOI: 10.1093/rap/rkac079

Authors with CRIS profile

Bernhard Manger Professur für Rheumatologie und Klinische Immunologie Georg Schett Lehrstuhl für Innere Medizin III Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Klinikum Bayreuth DE Germany (DE)

How to cite

APA:

Valor-Mendez, L., Dorn, C., Manger, B., Schett, G., & Kleyer, A. (2022). Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator. Rheumatology Advances in Practice, 6(3). https://dx.doi.org/10.1093/rap/rkac079

MLA:

Valor-Mendez, Larissa, et al. "Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator." Rheumatology Advances in Practice 6.3 (2022).

BibTeX: Download